ArticleProceedings of the National Academy of Sciences of the United States of America2017

Rationally designed PPARδ-specific agonists and their therapeutic potential for metabolic syndrome.

Rebecca L CoxPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.